NHIC Innovation to Develop (I2D)

Objective

The National Health Innovation Centre (NHIC) provides the publicly-funded clinical research sector of Singapore with translational funding and strategic guidance to accelerate healthcare innovation. Established in 2014, it supports the development of innovative technologies and services to improve healthcare delivery and patient care. NHIC aims to expedite the translation of an innovation towards a market-ready product and offers funding for IP protection and the development of projects with a commercialisable outcome for the publicly funded clinical community in Singapore. 

The Innovation to Develop (I2D) grant category:

• It aims to support the development of a clinically significant and/or commercially viable healthcare innovation.
• The grant application must clearly illustrate the scientific merit, competitive advantage and technical feasibility of the project.
• It must demonstrate potential for translation to a point where the technology would be attractive to an industry partner or follow-on funder.

Funding Details

The award includes up to $400K (inclusive of max. 30% indirect costs) over a period of 18 months.

Eligibility Criteria

• Applicants must hold primary appointment in a public healthcare institution and be salaried by the institution in Singapore.

• Project teams must have strong clinical representation.

• Collaborations with industry are encouraged if they strengthen the proposals.

• All applications are considered based on merit and eligibility is not limited to NMRC-funded research.

Submission

• Applicants are to submit the following completed files to SingHealth Intellectual Property Office, SHIP (SHIP@singhealth.com.sg) through Host Institution's Research Office for initial pre-review by 14 August (Friday), 5pm.
  • ‘NHIC-I2D Grant Application Form’ Word file
  • ‘NHIC-I2D-FORM-2: NHIC-I2D Application Template’ PowerPoint file
• (Additional resources – optional) Prior to submission to SHIP, applicants may also reach out to SingHealth Medical Technology Office (MTO; mto@singhealth.com.sg) on technical aspects to strengthen their proposal and to connect with the engineering ecosystem in SingHealth; and/or approach the Clinician Innovator Development Programme (CINDP) on questions of grantsmanship (cindp@duke-nus.edu.sg) with the subject heading: CINDP/NHIC application).
• Applicants will receive pre-review feedback from SHIP on the proposal through Host Institution's Research Office for revision within 4 weeks from submission to SHIP.
• The final proposal application needs to be signed by your respective Host Institution's Research Director prior to submission to SHIP. SHIP will assist to submit to NHIC.

Note: SingHealth PIs are to please refer to your respective Institutional Research Administrators for guidance on internal deadlines and submission procedures set by your institutions.

Contact Person in SHIP

Email: SHIP@singhealth.com.sg

Contact person in MTO

Email: mto@singhealth.com.sg

Contact person in CINDP

Email: add@duke-nus.edu.sg

Contact Person in NHIC

Email: grant@nhic.cris.sg

Additional Information

• Please download the latest application form from the website here.

• For more information on I2D, please visit NHIC's website here.